Operating Lease, Liability, Noncurrent of Pharma-Bio Serv, Inc. from 31 Oct 2019 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Pharma-Bio Serv, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Oct 2019 to 31 Jul 2025.
  • Pharma-Bio Serv, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 31 Jul 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 -$71,362 -100% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $0 -$113,044 -100% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $0 -$153,993 -100% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $28,834 -$165,201 -85% 31 Oct 2024 10-Q 15 Sep 2025 2025 Q3
Q2 2024 $71,362 -$161,914 -69% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $113,044 -$158,693 -58% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $153,993 -$155,571 -50% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $194,035 -$152,474 -44% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $233,276 -$149,440 -39% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $271,737 -$146,467 -35% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $309,564 -$143,714 -32% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $346,509 -$140,855 -29% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $382,716 -$141,244 -27% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $418,204 -$141,669 -25% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $453,278 -$141,794 -24% 31 Jan 2022 10-Q 17 Mar 2022 2022 Q1
Q3 2021 $487,364 -$142,615 -23% 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $523,960 -$139,826 -21% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $559,873 -$137,043 -20% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $595,072 -$134,317 -18% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $629,979 +$629,979 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $663,786 31 Jul 2020 10-Q 14 Sep 2020 2020 Q3
Q1 2020 $696,916 30 Apr 2020 10-Q 15 Jun 2020 2020 Q2
Q4 2019 $729,389 31 Jan 2020 10-Q 16 Mar 2020 2020 Q1
Q3 2019 $0 31 Oct 2019 10-K 01 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.